Retatrutide 24mg Pen

8 WEEK COURSE

Type:
Triple agonist (GLP-1, GIP, and glucagon receptor agonist).
Mechanism: Targets GLP-1, GIP, and glucagon receptors, offering a broader metabolic impact.

Benefits:
Maximum Weight Loss Potential: Preliminary studies suggest it may provide the most significant weight reduction among the three.

Multifaceted Metabolic Benefits:
Enhances energy expenditure, fat metabolism, and appetite control.

Superior Glucose Regulation:
Broad action leads to improved blood sugar control, particularly in insulin-resistant individuals.

Fat Mass Reduction:
Targets visceral and liver fat more effectively, reducing risks associated with fatty liver disease.

Future Promise:
May offer additional benefits for cardiovascular and liver health, given its broader scope of receptor activity.